Senior insider sale
PRESIDENT & CFO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$18.07M
310K shares
What this filing means
MORTIMER IAN plans to sell 310K shares of XENON PHARMACEUTICALS INC. valued at approximately $18.07M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/9/2026ACC: 0001193125-26-098734
Officer· PRESIDENT & CFO
Since Sep 2019
310K
Shares to sell
$18.07M
Approx. market value
270K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Options
Cash
3/9/2026
270KTotal acquired270K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/9/2026 | Exercise of Options Cash | 270K | — |
| Total | 270K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
40K
Market value
$1.78M
1/2/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
270K
Market value
$16.29M
3/9/2026
Total
Units
310K
Value
$18.07M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/2/2026 | 40K | $1.78M | — | Completed |
| Planned — Approximate Date | ||||
3/9/2026 | 270K | $16.29M | NASDAQ | Planned |
| Total | 310K | $18.07M | ||